Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports

BMC Pharmacol Toxicol. 2019 Feb 12;20(1):9. doi: 10.1186/s40360-019-0289-7.

Abstract

Background: True hypersensitivity reactions to rifampicin are relatively rare, nonetheless severe manifestations mostly involving a single organ have been documented. We report a case of acute multi-organ failure occurring after a medication error with re-exposure to rifampicin.

Case presentation: A 68-year old patient developed acute hypersensitivity pneumonitis, acute renal failure, acute liver failure and haemolytic anemia within hours after a second re-exposure to Rifampicin for the treatment of a hip prosthesis infection with Staphylococcus epidermidis. A recent rifampicin exposure 1 week earlier had resulted in a massive rise of CRP levels without organ manifestations. Nine years previously, the patient had developed a multi-organ hypersensitivity reaction 8 days after commencing treatment with rifampicin for pulmonary tuberculosis; and 23 years previously he had received rifampicin without problems. The organ-specific hypersensitivity reactions were largely reversible after withdrawal of rifampicin and treatment with steroids. A review of the literature and summary of WHO spontaneous safety reports is also given.

Conclusions: Re-exposure to rifampicin in sensitised individuals may cause acute severe hypersensitivity reactions. Due to its indications in the management of mycobacterial and implant-associated infections, rifampicin is a drug which might be given decades apart, which poses a risk that information about previous intolerance is lost.

Keywords: Hypersensitivity reaction; Multi-organ failure; Pharmacovigilance; Pneumonitis; Rifampicin.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Antibiotics, Antitubercular / adverse effects*
  • Drug Hypersensitivity / etiology*
  • Humans
  • Male
  • Multiple Organ Failure / chemically induced*
  • Rifampin / adverse effects*

Substances

  • Antibiotics, Antitubercular
  • Rifampin